Literature DB >> 27373493

Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.

Brian J Liddicoat1, Jochen C Hartner2, Robert Piskol3, Gokul Ramaswami3, Alistair M Chalk1, Paul D Kingsley4, Vijay G Sankaran5, Meaghan Wall6, Louise E Purton1, Peter H Seeburg7, James Palis4, Stuart H Orkin8, Jun Lu9, Jin Billy Li3, Carl R Walkley10.   

Abstract

Adenosine deaminases that act on RNA (ADARs) convert adenosine residues to inosine in double-stranded RNA. In vivo, ADAR1 is essential for the maintenance of hematopoietic stem/progenitors. Whether other hematopoietic cell types also require ADAR1 has not been assessed. Using erythroid- and myeloid-restricted deletion of Adar1, we demonstrate that ADAR1 is dispensable for myelopoiesis but is essential for normal erythropoiesis. Adar1-deficient erythroid cells display a profound activation of innate immune signaling and high levels of cell death. No changes in microRNA levels were found in ADAR1-deficient erythroid cells. Using an editing-deficient allele, we demonstrate that RNA editing is the essential function of ADAR1 during erythropoiesis. Mapping of adenosine-to-inosine editing in purified erythroid cells identified clusters of hyperedited adenosines located in long 3'-untranslated regions of erythroid-specific transcripts and these are ADAR1-specific editing events. ADAR1-mediated RNA editing is essential for normal erythropoiesis.
Copyright © 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27373493      PMCID: PMC5035604          DOI: 10.1016/j.exphem.2016.06.250

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  63 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

2.  Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment.

Authors:  Sofie Singbrant; Megan R Russell; Tanja Jovic; Brian Liddicoat; David J Izon; Louise E Purton; Natalie A Sims; T John Martin; Vijay G Sankaran; Carl R Walkley
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

3.  Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis.

Authors:  Ke Chen; Jing Liu; Susanne Heck; Joel A Chasis; Xiuli An; Narla Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

4.  An unwinding activity that covalently modifies its double-stranded RNA substrate.

Authors:  B L Bass; H Weintraub
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

5.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

Authors:  K A Lehmann; B L Bass
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  RED2, a brain-specific member of the RNA-specific adenosine deaminase family.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; M Higuchi; P H Seeburg
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

8.  C. elegans and H. sapiens mRNAs with edited 3' UTRs are present on polysomes.

Authors:  Heather A Hundley; Ammie A Krauchuk; Brenda L Bass
Journal:  RNA       Date:  2008-08-21       Impact factor: 4.942

9.  Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.

Authors:  Cornelia Vesely; Stefanie Tauber; Fritz J Sedlazeck; Arndt von Haeseler; Michael F Jantsch
Journal:  Genome Res       Date:  2012-02-06       Impact factor: 9.043

10.  The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

Authors:  Niamh M Mannion; Sam M Greenwood; Robert Young; Sarah Cox; James Brindle; David Read; Christoffer Nellåker; Cornelia Vesely; Chris P Ponting; Paul J McLaughlin; Michael F Jantsch; Julia Dorin; Ian R Adams; A D J Scadden; Marie Ohman; Liam P Keegan; Mary A O'Connell
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

View more
  26 in total

Review 1.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

2.  ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.

Authors:  Richard de Reuver; Simon Verdonck; Evelien Dierick; Josephine Nemegeer; Eline Hessmann; Sadeem Ahmad; Maude Jans; Gillian Blancke; Filip Van Nieuwerburgh; Alexander Botzki; Lars Vereecke; Geert van Loo; Wim Declercq; Sun Hur; Peter Vandenabeele; Jonathan Maelfait
Journal:  Nature       Date:  2022-07-20       Impact factor: 69.504

3.  Genetic architecture of RNA editing regulation in Alzheimer's disease across diverse ancestral populations.

Authors:  Olivia K Gardner; Derek Van Booven; Lily Wang; Tianjie Gu; Natalia K Hofmann; Patrice L Whitehead; Karen Nuytemans; Kara L Hamilton-Nelson; Larry D Adams; Takiyah D Starks; Michael L Cuccaro; Eden R Martin; Jeffery M Vance; William S Bush; Goldie S Byrd; Jonathan L Haines; Gary W Beecham; Margaret A Pericak-Vance; Anthony J Griswold
Journal:  Hum Mol Genet       Date:  2022-08-25       Impact factor: 5.121

Review 4.  Epitranscriptomics in Hematopoiesis and Hematologic Malignancies.

Authors:  Margalida Rosselló-Tortella; Gerardo Ferrer; Manel Esteller
Journal:  Blood Cancer Discov       Date:  2020-06-22

5.  Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.

Authors:  Charles J Cho; Jaeeun Jung; Lushang Jiang; Eun Ji Lee; Dae-Soo Kim; Byung Sik Kim; Hee Sung Kim; Hwoon-Yong Jung; Ho-June Song; Sung Wook Hwang; Yangsoon Park; Min Kyo Jung; Chan Gi Pack; Seung-Jae Myung; Suhwan Chang
Journal:  Dig Dis Sci       Date:  2018-04-25       Impact factor: 3.199

6.  ADAR1-mediated RNA editing is required for thymic self-tolerance and inhibition of autoimmunity.

Authors:  Taisuke Nakahama; Yuki Kato; Jung In Kim; Tuangtong Vongpipatana; Yutaka Suzuki; Carl R Walkley; Yukio Kawahara
Journal:  EMBO Rep       Date:  2018-10-25       Impact factor: 8.807

7.  RNA editing signature during myeloid leukemia cell differentiation.

Authors:  C Rossetti; E Picardi; M Ye; G Camilli; A M D'Erchia; L Cucina; F Locatelli; L Fianchi; L Teofili; G Pesole; A Gallo; R Sorrentino
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

Review 8.  Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.

Authors:  Carl R Walkley; Jin Billy Li
Journal:  Genome Biol       Date:  2017-10-30       Impact factor: 13.583

9.  Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.

Authors:  Jacki E Heraud-Farlow; Alistair M Chalk; Sandra E Linder; Qin Li; Scott Taylor; Joshua M White; Lokman Pang; Brian J Liddicoat; Ankita Gupte; Jin Billy Li; Carl R Walkley
Journal:  Genome Biol       Date:  2017-09-05       Impact factor: 13.583

Review 10.  RNA modifications in hematopoietic malignancies: a new research frontier.

Authors:  Ying Qing; Rui Su; Jianjun Chen
Journal:  Blood       Date:  2021-08-26       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.